Compare Star Bulk Carriers Corp (SBLK) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Star Bulk Carriers Corp vs TransMedics Group Inc — how do they compare? Star Bulk Carriers Corp trades at $31.1 (market cap $3.48B), while TransMedics Group Inc trades at $86.5 (market cap $3.00B). The key difference: Star Bulk Carriers Corp is the larger of the two by market cap, and Star Bulk Carriers Corp pays a 6.03% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| SBLK | TMDX | |
|---|---|---|
Market Cap | $3.48B | $3.00B |
Sector | Industrials | Technology |
52-Week High | $32.42 | $150.42 |
52-Week Low | $16.79 | $61.99 |
Enterprise Value | $4.16B | $3.39B |
Dividend Yield | 6.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Star Bulk Carriers (SBLK) trades at $31.02, down 4.32% over 24 hours, with strong technical momentum indicated by bullish moving averages. The company reported robust Q2 2026 earnings of $1.21 per share, beating estimates, and maintains solid profitability with a net income margin of 23.87%. Recent news highlights its inclusion in top income and value stock lists, while a parallel listing in Greece aims to raise capital.
SBLK presents a compelling investment case with consistent earnings beats, high dividend yields, and favorable analyst sentiment. Key risks include exposure to volatile freight rates and geopolitical tensions. The stock's current valuation metrics suggest potential upside, supported by institutional accumulation and positive cash flow trends.
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company reported strong 2025 results with $605M revenue and 31.4% net margin, though 2026 projections show margin compression. Recent news highlights growth initiatives in kidney transplantation and European markets, alongside ongoing legal investigations into fiduciary duties.
The stock offers upside to the $99.57 consensus price target, supported by analyst bullishness (69% buy ratings), but faces risks from margin pressure, legal scrutiny, and earnings misses. Revenue growth remains a key catalyst, though execution risks and investor sentiment headwinds warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
